Safety and pharmacokinetics of teplizumab in children less than 8 years of age with stage 2 type 1 diabetes

This article has no abstract
Epistemonikos ID: 5b201227d8b9f61525247bc7e35a295927dc256a
First added on: Nov 21, 2025